Pharmaceutical Technology's Equipment and Machinery Spending Survey - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology's Equipment and Machinery Spending Survey
The pharmaceutical industry plans moderate increases in spending for equipment and machinery in 2007 as expenditures hold steady.

Pharmaceutical Technology



Figure 3
The increase in the percentage of respondents indicating spending of 2.1–4% of their overall company's revenues seems to have come at the expense of higher levels of spending.Three ranges of spending declined in 2007 over 2006. Only 6.4% of respondents say their companies plan to spend 6.1–8% of their overall revenues on equipment and machinery in 2007, compared with 12.2% in 2006. Only 4.2% plan to spend 8.1–10% of their overall revenues on machinery and equipment in 2007, compared with 6.2% in 2006. And, only 4.3% plan to spend greater than 10% of their overall revenues on equipment and machinery in 2007, compared to 12.2% in 2006.

In terms of absolute dollar amounts, almost three-fourths of the respondents (72.3%) say their companies plan to spend $10 million or less on equipment and machinery in 2007 (see Figure 3). In 2006, 60.4% of the respondents said their companies increased spending by $10 million or less, and 18.8% increased spending by $11–50 million (see Figure 3).


Figure 4
For 2007, spending at moderate levels is increasing over 2006. In 2007, 12.5% of the respondents plan to increase spending 4.1-6%; only 6.3% increased spending by this level in 2006. In 2007, 29.2% of the respondents plan to increase spending by 2.1-4%; in 2006, only 18.7% increased spending by this level. (see Figure 4).



Spending trends


Figure 5
In analyzing spending trends, 46.8% of respondents said that their company's growth in spending on machinery and equipment is holding steady, and 8.5% of respondents said their spending will grow faster in 2007 than in 2006 (see Figure 5). Over the past two years (2006 and 2005), 40.8% said that spending growth held steady, and 20.4% said that it grew faster year over year. Consistent with 2005 and 2006 spending levels, 10.6% of respondents say spending on equipment and machinery is contracting in 2007 (spending less in 2007 than in 2006), and 21.3% of respondents say their spending growth is slowing (rate of increase is less year-over-year).

Reasons for increasing spending


Figure 6
Facilities expansion and new or expanded projects were the major reasons behind growth in spending in 2006 and planned spending for 2007 (see Figure 6). In 2006, 71.4% of respondents increased spending on machinery and equipment because of facilities expansion or new or expanded projects, and 78.1% responded similarly for spending planned in 2007. Roughly one-quarter (21.9% in 2007 and 25.7% in 2006) of the respondents said spending growth resulted from the replacement of existing equipment.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
10%
Provide treatment for patients globally.
6%
All of the above.
42%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here